GT-002

N/A

Report date: 2024/04/11 15:11:34
NME

Base Information

Drug NameGT-002
Drug Alias NameGT-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA-A receptor; benzodiazepine site modulators
TargetsGABA-A receptor; benzodiazepine site
Therapy Area/IndicationsSchizophreniaCognition DisordersMental Disorders +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenFinland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLund University
China Registration ClassN/A

Develop Information

Active CompaniesGabather Ab
Active IndicationsSchizophreniaCognition DisordersDementia
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A